GJD2 and depressive symptom measurement: It was the first time to discover that expression of Cx36 was increased significantly in the hippocampus of mice exposed to CUMS, while treatment with GZA obviously improved depressive symptoms through down‐regulation of Cx36, suggesting that Cx36 might play a destructive role in depression.